Shares of Field Trip Health Ltd. (TSE:FTRP – Get Free Report) were up 5.8% on Monday . The stock traded as high as C$1.11 and last traded at C$1.09. Approximately 97,451 shares traded hands during trading, an increase of 165% from the average daily volume of 36,819 shares. The stock had previously closed at C$1.03.
Field Trip Health Price Performance
The company has a debt-to-equity ratio of 43.39, a current ratio of 8.20 and a quick ratio of 7.70. The stock has a market capitalization of C$12.68 million and a P/E ratio of -1.22. The firm has a 50-day moving average price of C$1.09.
About Field Trip Health
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions.
Read More
- Five stocks we like better than Field Trip Health
- High Flyers: 3 Natural Gas Stocks for March 2022
- United Airlines Soars on Earnings Beat
- 3 Fintech Stocks With Good 2021 Prospects
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Market Cap Calculator: How to Calculate Market Cap
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Field Trip Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Field Trip Health and related companies with MarketBeat.com's FREE daily email newsletter.
